Clinical Trials Logo

Filter by:
NCT ID: NCT01958918 Completed - Clinical trials for Neovascular Age-related Macular Degeneration

Efficacy of Ranibizumab Prn Treatment Compared to Aflibercept Bimonthly Intravitreal Injections on Retinal Thickness Stability in Patients With Wet AMD

SALT
Start date: October 23, 2013
Phase: Phase 4
Study type: Interventional

The purpose of this study was to compare the efficacy of 0.5 mg ranibizumab versus 2 mg aflibercept bimonthly intravitreal injections on retinal thickness stability.

NCT ID: NCT01958021 Completed - Clinical trials for Advanced, Metastatic Breast Cancer

Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer.(MONALEESA-2)

MONALEESA-2
Start date: December 17, 2013
Phase: Phase 3
Study type: Interventional

This is a multi-center, randomized, double-blinded, placebo controlled trial.

NCT ID: NCT01957878 Completed - Clinical trials for HUMAN PAPILLOMA VIRUS

Phase II Study of HPV Therapeutic Vaccine in HPV Infected Women With Normal Cytology or ASCUS/LSIL

RHEIA-VAC
Start date: December 2013
Phase: Phase 2
Study type: Interventional

Human Papillomavirus (HPV) 16 and HPV 18 (the two virus genotypes targeted by the ProCervix vaccine) are the most common HPV genotypes associated with at least 70% of squamous cell carcinomas and 82% of adenocarcinomas of the cervix The strategy of therapeutic vaccination with ProCervix is to activate and enhance the patient's cellular immune response to HPV . The therapeutic vaccine will be used for women infected by HPV 16, HPV 18, or both. The vaccine targets these HPV infected women with normal or mild cervical cellular dyskaryosis as detectable infections with oncogenic potential. This will be a double-blind, randomised, placebo-controlled, parallel group study assessing the efficacy of ProCervix or placebo (concomitantly administered with imiquimod cream). ProCervix will be delivered with a topical agent, imiquimod, applied to the injection sites as a vaccine adjuvant. The population proposed for this study represents an otherwise healthy female population who are infected with HPV 16 and/or HPV 18. The safety and tolerability of this therapeutic vaccine has been shown in the ongoing Phase I study, and the proposed population may in theory derive benefit from this vaccine.

NCT ID: NCT01957553 Completed - Ileostomy - Stoma Clinical Trials

Investigating the Safety and Performance of a New 2-piece Ostomy Product Compared With SenSura Click 2-piece

Start date: September 2013
Phase: N/A
Study type: Interventional

The aim of the current investigation is to investigate the performance of a new 2-piece ostomy product

NCT ID: NCT01957176 Completed - Thrombocytopaenia Clinical Trials

A Rollover Study to Provide Continued Treatment With Eltrombopag

Start date: October 15, 2013
Phase: Phase 4
Study type: Interventional

The objective of this study was to provide continued treatment with eltrombopag for subjects who were participating in a Novartis-sponsored investigational study with eltrombopag (parent studies 114968/ASPIRE (NCT01440374), PMA112509 (NCT00903422), and TRA105325/EXTEND (NCT00351468), receiving clinical benefit without unacceptable toxicity and to collect long-term safety data.

NCT ID: NCT01956123 Completed - Infertility Clinical Trials

Evidence-based Stimulation Trial With Human rFSH in Europe and Rest of World 2

ESTHER-2
Start date: March 26, 2014
Phase: Phase 3
Study type: Interventional

This trial investigates the immunogenicity of FE 999049 in repeated cycles.

NCT ID: NCT01956110 Completed - Infertility Clinical Trials

Evidence-based Stimulation Trial With Human rFSH in Europe and Rest of World 1

ESTHER-1
Start date: October 2013
Phase: Phase 3
Study type: Interventional

This trial investigates the effects of FE 999049 compared to GONAL-F.

NCT ID: NCT01955720 Completed - Hemorrhage Clinical Trials

Safety, Tolerability, PK and PD of BI 655075 and Establishment of BI 655075 Dose(s) Effective to Reverse Prolongation of Blood Coagulation Time by Dabigatran

Start date: September 2013
Phase: Phase 1
Study type: Interventional

To investigate safety, tolerability, PK and PD of BI 655075 and to establish the BI 655075 dose(s) effective to reverse prolongation of blood coagulation time by dabigatran

NCT ID: NCT01955161 Completed - Alzheimer's Disease Clinical Trials

Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil

STARSHINE
Start date: October 2013
Phase: Phase 3
Study type: Interventional

To establish efficacy of idalopirdine as adjunctive therapy to donepezil for symptomatic treatment of patients with mild-to-moderate Alzheimer's disease (AD).

NCT ID: NCT01954758 Completed - Clinical trials for Endometrial Receptivity

The ERA Test as a Diagnostic Guide for Personalized Embryo Transfer

ERA RCT
Start date: November 25, 2013
Phase: N/A
Study type: Interventional

This project seeks to demonstrate the clinical value of the personalised diagnosis of the endometrial factor in infertility.